Outcome and complications of outpatient parenteral therapy in pediatric emergency utilizing only peripheral vascular access

References

1. 1.↵
   1. Rucker RW,
   2. Harrison GM

   . Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974; 54: 358–360.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Baskin MN,
   2. O’Rourke EJ,
   3. Fleisher GR

   . Outpatient treatment of febrile infants 28-89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992; 120: 22–27.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Güven A

   . Intramuscular antibiotic treatment of urinary tract infection. Indian J Pediatr 2004; 71: 979–981.

   OpenUrlPubMed
4. 4.↵
   1. Shemesh E,
   2. Yaniv I,
   3. Drucker M,
   4. Hadad S,
   5. Goshen Y,
   6. Stein J, et al.

   Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients. Med Pediatr Oncol 1998; 30: 95–100.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Girón RM,
   2. Martínez A,
   3. Máiz L,
   4. Salcedo A,
   5. Beltrán B,
   6. Martínez MT, et al.

   [Home intravenous antibiotic treatments in cystic fibrosis units of Madrid]. Med Clin (Barc) 2004; 122: 648–652. [In Spanish].

   OpenUrlPubMed
6. 6.↵
   1. Ibrahim LF,
   2. Hopper SM,
   3. Orsini F,
   4. Daley AJ,
   5. Babl FE,
   6. Bryant PA

   . Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, and non-inferiority trial. Lancet Infect Dis 2019; 19: 477–486.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Mendoza-Ruiz de Zuazu H,
   2. Casas-Arrate J,
   3. Martínez-Martínez C,
   4. de la Maza I,
   5. Regalado de los Cobos J, et al.

   [Home intravenous antibiotic treatment: a study in 515 patients]. Enferm Infecc Microbiol Clin 2005; 23: 396–401. [In Spanish].

   OpenUrlPubMed
8. 8.↵
   1. Caplan GA,
   2. Sulaiman NS,
   3. Mangin DA,
   4. Aimonino Ricauda N,
   5. Wilson AD,
   6. Barclay L

   . A meta-analysis of “hospital in the home”. Med J Aust 2012; 197: 512–519.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Sartain SA,
   2. Maxwell MJ,
   3. Todd PJ,
   4. Haycox AR,
   5. Bundred PE

   . Users’ views on hospital and home care for acute illness in childhood. Health Soc Care Community 2001; 9: 108–117.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Zdun-Ryżewska A,
    2. Nadrowska N,
    3. Błażek M,
    4. Białek K,
    5. Zach E,
    6. Krywda-Rybska D

    . Parent’s stress predictors during a child’s hospitalization. Int J Environ Res Public Health 2021; 18: 12019.

    OpenUrl
11. 11.
    1. Macías M,
    2. Zornoza C,
    3. Rodriguez E,
    4. García JA,
    5. Fernández JA,
    6. Luque R, et al.

    Impact of hospital admission care at a pediatric unit: a qualitative study. Pediatr Nurs 2015; 41: 285–294.

    OpenUrl
12. 12.
    1. Sahiledengle B,
    2. Seyoum F,
    3. Abebe D,
    4. Geleta EN,
    5. Negash G,
    6. Kalu A, et al.

    Incidence and risk factors for hospital-acquired infection among paediatric patients in a teaching hospital: a prospective study in southeast Ethiopia. BMJ Open 2020; 10: e037997.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Ali S,
    2. Birhane M,
    3. Bekele S,
    4. Kibru G,
    5. Teshager L,
    6. Yilma Y, et al.

    Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia: longitudinal study. Antimicrob Resist Infect Control 2018; 7: 2.

    OpenUrl
14. 14.
    1. Russell H,
    2. Hall M,
    3. Morse RB,
    4. Cutler GJ,
    5. Macy M,
    6. Bettenhausen JL, et al.

    Longitudinal trends in costs for hospitalizations at children’s hospitals. Hosp Pediatr 2020; 10: 797–801.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gill PJ,
    2. Thavam T,
    3. Anwar MR,
    4. Zhu J,
    5. Parkin PC,
    6. Cohen E, et al.

    Prevalence, cost, and variation in cost of pediatric hospitalizations in Ontario, Canada. JAMA Netw Open 2022; 5: e2147447.

    OpenUrl
16. 16.↵
    1. Reid S,
    2. Bonadio W

    . Feasibility of short-term outpatient intravenous antibiotic therapy for the management of infectious conditions in pediatric patients. Am J Emerg Med 2006; 24: 839–842.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Suau CT,
    2. Piñera MC,
    3. Díaz WS,
    4. Troncoso RE

    . [Outpatient parenteral antimicrobial therapy: an alternative to hospitalization in a pediatric emergency department]. Rev Chilena Infectol 2008; 25: 374–378. [In Spanish].

    OpenUrlPubMed
18. 18.↵
    1. Smith JK,
    2. Alexander S,
    3. Abrahamson E

    . Ambulatory intravenous ceftriaxone in paediatric A&E: a useful alternative to hospital admission? Emerg Med J 2011; 28: 877–881.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Orme LM,
    2. Babl FE,
    3. Barnes C,
    4. Barnett P,
    5. Donath S,
    6. Ashley DM

    . Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial. Pediatr Blood Cancer 2014; 61: 1427–1433.

    OpenUrlCrossRefPubMed
20. 20.
    1. Ibrahim LF,
    2. Hopper SM,
    3. Connell TG,
    4. Daley AJ,
    5. Bryant PA,
    6. Babl FE

    . Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate/severe cellulitis. Emerg Med J 2017; 34: 780–785.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Ibrahim LF,
    2. Hopper SM,
    3. Babl FE,
    4. Bryant PA

    . Who can have parenteral antibiotics at home? A prospective observational study in children with moderate/severe cellulitis. Pediatr Infect Dis J 2016; 35: 269–274.

    OpenUrlCrossRefPubMed
22. 22.
    1. Gouin S,
    2. Chevalier I,
    3. Gauthier M,
    4. Lamarre V

    . Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre. J Paediatr Child Health 2008; 44: 214–218.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Brugha RE,
    2. Abrahamson E

    . Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis. Pediatr Emerg Care 2012; 28: 226–228.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.
    1. Gauthier M,
    2. Chevalier I,
    3. Sterescu A,
    4. Bergeron S,
    5. Brunet S,
    6. Taddeo D

    . Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics 2004; 114: e469–e476.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.
    1. Doré-Bergeron MJ,
    2. Gauthier M,
    3. Chevalier I,
    4. McManus B,
    5. Tapiero B,
    6. Lebrun S

    . Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics. Pediatrics 2009; 124: 16–22.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Alkhateeb A,
    2. Morin F,
    3. Aziz H,
    4. Manogaran M,
    5. Guertin W,
    6. Duval M

    . Outpatient management of pediatric acute mastoiditis. Int J Pediatr Otorhinolaryngol 2017; 102: 98–102.

    OpenUrl
27. 27.↵
    1. Howard LM,
    2. Thurm C,
    3. Dantuluri K,
    4. Griffith HG,
    5. Katz SE,
    6. Ward MJ, et al.

    Parenteral antibiotic use among ambulatory children in United States Children’s Hospital Emergency Departments. Open Forum Infect Dis 2020; 7: ofaa357.

    OpenUrl
28. 28.↵
    1. Xu M,
    2. Doan Q

    . Outpatient parenteral antimicrobial therapy and ludicious use of pediatric emergency resources. Pediatr Emerg Care 2020; 36: e247–e253.

    OpenUrl
29. 29.↵
    1. Madigan T,
    2. Banerjee R

    . Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children’s hospital. Pediatr Infect Dis J 2013; 32: 346–349.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Townsley E,
    2. Gillon J,
    3. Jimenez-Truque N,
    4. Katz S,
    5. Garguilo K,
    6. Banerjee R

    . Risk factors for adverse events in children receiving outpatient parenteral antibiotic therapy. Hosp Pediatr 2021; 11: 153–159.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Hodgson KA,
    2. Huynh J,
    3. Ibrahim LF,
    4. Sacks B,
    5. Golshevsky D,
    6. Layley M, et al.

    The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Arch Dis Child 2016; 101: 886–893.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Hendarto A,
    2. Putri ND,
    3. Yunita DR,
    4. Efendi M,
    5. Prayitno A,
    6. Karyanti MR, et al.

    First pediatric outpatient parenteral antibiotic therapy clinic in Indonesia. Front Pediatr 2020; 8: 156.

    OpenUrl
33. 33.↵
    1. Carter B,
    2. Fisher-Smith D,
    3. Porter D,
    4. Lane S,
    5. Peak M,
    6. Taylor-Robinson D, et al.

    Paediatric outpatient parenteral antimicrobial therapy (OPAT): an e-survey of the experiences of parents and clinicians. PLoS One 2021; 16: e0249514.

    OpenUrl
34. 34.↵
    1. Goldman JL,
    2. Richardson T,
    3. Newland JG,
    4. Lee B,
    5. Gerber JS,
    6. Hall M, et al.

    Outpatient parenteral antimicrobial therapy in pediatric medicaid enrollees. J Pediatric Infect Dis Soc 2017; 6: 65–71.

    OpenUrlPubMed
35. 35.↵
    1. Frenkel LD

    . Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children. Pediatrics 1988; 82: 486–491.

    OpenUrlPubMed
36. 36.↵
    1. Shalviri G,
    2. Yousefian S,
    3. Gholami K

    . Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre. J Clin Pharm Ther 2012; 37: 448–451.

    OpenUrlPubMed
37. 37.↵
    1. McMullan BJ,
    2. Andresen D,
    3. Blyth CC,
    4. Avent ML,
    5. Bowen AC,
    6. Britton PN, et al.

    Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis 2016; 16: e139–e152.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Le J,
    2. San Agustin M,
    3. Hernandez EA,
    4. Tran TT,
    5. Adler-Shohet FC

    . Complications associated with outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila) 2010; 49: 1038–1043.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Paolino J,
    2. Mariani J,
    3. Lucas A,
    4. Rupon J,
    5. Weinstein H,
    6. Abrams A, et al.

    Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia. Pediatr Blood Cancer 2019; 66: e27679.

    OpenUrl
40. 40.↵
    1. Cabrera López IM,
    2. Agúndez Reigosa B,
    3. Adrados García S,
    4. Villalobos Pinto E,
    5. Cano Fernández J,
    6. Jiménez García R

    . Home-hospital care for children with acute illnesses: a 2-year follow-up study. J Paediatr Child Health 2022; 58: 969–977.

    OpenUrl